Fresenius Medical Care (FME.DE) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN DE0005785802
Fresenius Medical Care financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 19.34 bn EUR | 19.63 bn EUR |
| Gross profit | 4.76 bn EUR | 5.03 bn EUR |
| Operating income | 1.54 bn EUR | 1.87 bn EUR |
| EBIT | 1.39 bn EUR | 1.83 bn EUR |
| Net income | 537.00 m EUR | 978.00 m EUR |
| Diluted EPS – continuing operations | 1.83 EUR | 3.42 EUR |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
More stocks
- Olympus Corp (7733.T)
- Eneva S.A (ENEV3.SA)
- Kokusai Electric Corp (6525.T)
- Power Construction Corp of China Ltd (601669.SS)
- Standard Life PLC (SDLF.L)
- HKT Trust and HKT Ltd (6823.HK)
- Swiss Prime Site AG (SPSN.SW)
- Getlink SE (GET.PA)
- Western Mining Co Ltd (601168.SS)
- Posco Chemical Co Ltd (003670.KS)
- Saipem SpA (SPM.MI)
- Samsung SDS Co Ltd (018260.KS)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.